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Abstract
Background: Surveillance examining the incidence of community-associated methicillin-resistant Staphylococcus
aureus (CA-MRSA) was conducted over 8 years beginning in 2001 in three health regions covering the northern
half of Saskatchewan. The annual rate of individuals reported with CA-MRSA infection in these regions dramatically
increased from 8.2 per 10,000 population in 2001 (range to 4.4-10.1 per 10,000) to 168.1 per 10,000 in 2006 (range
43.4-230.9 per 10,000). To address this issue, a team of community members, healthcare professionals, educators
and research scientists formed a team called “the Northern Antibiotic Resistance Partnership” (NARP) to develop
physician, patient, community, and school based educational materials in an attempt to limit the spread of CA-
MRSA.
Methods: Posters, radio broadcasts, community slide presentations, physician treatment algorithms, patient
pamphlets, and school educational programs Do Bugs Need Drugs http://www.dobugsneeddrugs.org and Germs
Away http://www.germsaway.ca were provided to targeted northern communities experiencing high rates of
infections.
Results: Following implementation of this program, the rates of MRSA infections in the targeted communities
have decreased nearly two-fold (242.8 to 129.3 infections/10,000 population) from 2006 to 2008. Through pre-and
post-educational intervention surveys, this decrease in MRSA infections coincided with an increase in knowledge
related to appropriate antimicrobial usage and hand washing in these communities.
Conclusion: These educational materials are all freely available http://www.narp.ca and will hopefully aid in
increasing awareness of the importance of proper antimicrobial usage and hygiene in diminishing the spread of S.
aureus and other infectious diseases in other communities.
Background
Community-associated methicillin-resistant Staphylococ-
cus aureus ( C A - M R S A )i sa ne m e r g i n gp a t h o g e ni n
North America. These strains differ from typical health-
care associated MRSA in that they often harbour the
Panton-Valentine Leukocidin (PVL) toxin, and are gen-
erally more susceptible to classes of antimicrobials other
than the beta-lactam derived drugs, although increasing
resistance to antimicrobials are now being reported in
many PVL positive CA-MRSA isolates [1]. These CA-
MRSA strains have been associated primarily with skin
and soft tissue infections [2-4] with increased morbidity
and mortality [5], and are now entering and being disse-
minated within health care facilities [6].
In the 1990s CA-MRSA had been reported only spora-
dically in Canada [7,8]. However, since that time two
main CA-MRSA strains have emerged in Canada,
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CMRSA10 (similar to USA300; ST8-MRSA-IV)
[2,6,9,10]. CMRSA10 has been identified predominantly
in the western provinces of Canada and high incidences
have been reported in the homeless, incarcerated, and
intravenous drug user populations in the Calgary [11,12]
and Vancouver [13] health regions. CMRSA7 was first
reported in Manitoba causing an outbreak in the south-
ern portion of that province in the late 1990’s, but
spread to northern regions of the province [14-16] and
communities further north in Nunavut [17]. CMRSA7
was thereafter seen in central eastern [4] and northern
Saskatchewan with annual crude rates of infections as
high as 482 per 10,000 population in some communities
[2].
Anecdotal evidence from northern Saskatchewan and
other Canadian communities suggests that physicians
and prescribing nurses frequently opt to empirically pre-
scribe antimicrobials without obtaining laboratory iden-
tification of the infecting organism or drug resistance. It
has therefore been speculated that liberal antimicrobial
prescribing practices in northern communities may con-
tribute to community acquisition of CA-MRSA [3]. In a
previous northern Saskatchewan case control study, the
average number of antimicrobials prescribed in the year
prior to acquiring a CA-MRSA infection was 2.5 (med-
ian 2, range 0-10) [3]. Previous antimicrobial usage is a
known risk factor for acquiring CA-MRSA [18] and a
recent intervention study in children has demonstrated
that decreasing unnecessary usage can decrease the pre-
valence of MRSA in a community setting [19]. Data
obtained for the treatment of CA-MRSA infections in
northern Saskatchewan communities also revealed that
a high proportion of individuals (88.7%) were prescribed
antimicrobials, of which 57.1% were treated with a b-
lactam, which could be contributing to treatment fail-
ures, recurrent infections, and/or further dissemination
of CA-MRSA within these communities [3].
In this report, we describe the rapid emergence of
CA-MRSA in northern regions of Saskatchewan and the
potential effect of a community-based educational inter-
vention http://www.narp.ca to limit its spread in tar-
geted communities.
Methods
Study area
The study area included three northern health regions
in Saskatchewan: Athabasca Health Authority (AHA),
Keewatin Yatthé Health Region (KYHR), and Mamawe-
tan Churchill River Health Region (MCRHR) http://
www.health.gov.sk.ca/health-regions-map. This 317,000
km
2 (122,400 miles
2) boreal forest area includes 35,819
people (Saskatchewan Health, 2010) with 86% of Abori-
ginal descent (either First Nation or Métis) with 46%
living in First Nation “reserve” communities (Statistics
Canada). Health care services ranged from primary care
nursing health centers with weekly fly-in physician
clinics to a 40-bed hospital with resident physicians.
Determination of case incidence
A MRSA case was defined as a laboratory isolation of
MRSA from an infection site. Isolates from the nose or
groin without specification of an infection or an unspe-
cified screening or swab, and isolates obtained from an
individual less than 2 months from previous isolates
were excluded. Isolates with information associated with
characteristics of healthcare-associated MRSA (HA-
MRSA) were also excluded. Healthcare-associated cases
included post-surgical infections, dialysis, long-term care
residence, or indwelling catheter or percutaneous medi-
cal device.
Data collection
The study was conducted over 8 years from January 1,
2001 to December 31, 2008. Laboratory identification of
all MRSA cases were reported to the First Nations and
regional health Medical Health Officers. Over the 8 year
study period, a total of 3317 MRSA isolates were sub-
mitted from the three northern Saskatchewan health
regions. Of these, 586 isolates did not meet the inclu-
sion criteria of this study and were excluded from
further analysis. The remaining 2731 isolates were iden-
tified as cases of CA-MRSA.
Educational intervention
In an attempt to address the increasing CA-MRSA rates
in these regions, a two pronged educational strategy was
developed and approved by the University of Manitoba,
University of Saskatchewan, and Health Canada Research
Ethics Boards. The first approach involved educational
activities aimed at healthcare providers, which included
the development and implementation of an active sur-
veillance system to enhance the collection of data, includ-
ing microbiologic information (organism identification
and susceptibility data), prescribing practices, and general
patient demographic information for clients in 3 commu-
nities in northern Saskatchewan from October 2005-
March 2008 [2]. Secondly, a case-control study was
initiated in September 2004-March 2007 to determine
the risk factors associated with CA-MRSA infections [3].
The information gained from these 2 projects were
reported to physicians and healthcare providers, which
included the development and distribution of local guide-
lines for management of suspected CA-MRSA skin and
soft tissue infections (available at http://www.narp.ca).
Physician offices and community health centers were also
provided with information pamphlets describing MRSA
for distribution.
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crobial resistance issues through educational activities
aimed at the community. From a community perspec-
tive, posters describing the study, radio interviews, and
slide presentations about antibiotic resistance and CA-
MRSA were provided to the targeted communities.
Radio broadcasts were also developed and broadcast on
local radio stations in English, Cree, and Dene to further
educate the general public on skin and soft tissue infec-
tions, hand washing, and completing the entire course
of antibiotics. From a community perspective, pre-
(2006) and post-education (2008) surveys were distribu-
ted in an attempt to capture knowledge translation of
these NARP educational materials. In 2006, training ses-
sions for an existing educational program Do Bugs Need
Drugs http://www.dobugsneeddrugs.org was rolled-out
into the targeted communities for children in grades K-
3 (ages 5-8). To determine the potential effectiveness of
the Do Bugs Need Drugs program a pocket chart was
developed and utilized before and several months fol-
lowing the implementation of this program in the class-
rooms. In 2007, the Germs Away curriculum was
developed for students in grades 4-6 (ages 9-11) and
piloted in 19 northern Saskatchewan schools. The 7
activities in the Germs Away curriculum aimed to intro-
duce basic concepts related to the spread of infectious
diseases through contact, with learning outcomes related
to health and science. The site also included desktop
wallpapers, posters, hand washing posters aimed at chil-
dren, and a teacher’s section offering all Germs Away
teaching resources. Germs Away also includes a newly
developed interactive video game http://www.germs-
away.ca, which was developed to supplement the Germs
Away curriculum, but was not available during the
intervention period. The Germs Away curriculum and
game is available in English and French.
It should be noted that a couple of additional north-
ern Saskatchewan schools outside the targeted commu-
nities had received some of the school-based
educational components of the intervention in 2006
with some additional spill over to other northern com-
munities in late 2008. All primary healthcare providers
in the northern areas were also provided with the CA-
MRSA treatment/management algorithms in 2006/7.
Results and discussion
Over the 8 year study period, the annual rate of indivi-
duals reported with CA-MRSA infection in northern
Saskatchewan have dramatically increased from 8.2 per
10,000 population in 2001 to 142.6 per 10,000 in 2008,
which is almost 10 times higher than all reported MRSA
cases in neighboring northern Manitoba health regions
[14] and the province of Alberta [12]. The reporting
structure is similar between Saskatchewan and Alberta,
but the Manitoba rates included both colonizations/
infections and did not differentiate between HA- and
CA-MRSA strains, which further highlights the rapid
emergence and dissemination of CA-MRSA in northern
Saskatchewan.
The majority of isolates were obtained from skin and
soft tissue infections (78.2%), followed by ear (6.7%),
urogenital (2.4%), respiratory (1.1%), and joint/blood
infections (0.4%). A total of 11.2% of the infections were
unspecified. Molecular typing of a subset of 404 isolates
by pulsed-field gel electrophoresis revealed CMRSA7 to
be the predominant strain type (92.3%) followed by
CMRSA10 (4.7%). These results are similar to those pre-
viously described in specific northern Saskatchewan
communities dealing with high rates of CA-MRSA
infections [2,3], suggesting clonal dissemination of
CMRSA7 throughout the northern regions of the
province.
To help address the rapid emergence and dissemina-
tion of CA-MRSA in northern Saskatchewan, a team of
community members, healthcare professionals, educa-
tors and research scientists formed a team called NARP
http://www.narp.ca and established: 1) An active surveil-
lance program in target northern Saskatchewan commu-
nities [2]; 2) A case-control study to determine risk
factors for the acquisition of CA-MRSA [3]; and 3) A
community, school, and health worker educational
initiative through a collaboration of federal, provincial,
regional and First Nations health authorities and
laboratories.
Following implementation of this educational pro-
gram, the rates of MRSA infections in the targeted com-
munities have decreased nearly two-fold (243 to 129
infections/10,000 population) from 2006 to 2008, in
comparison to other non-target northern communities
in Saskatchewan where the rates have continued to
increase (119 to 151 infections/10,000 population) over
t h es a m et i m ep e r i o d( F i g u r e1 ) .T h i sd e c r e a s ei nC A -
MRSA infections in the targeted communities was
observed across all age groups examined and was not
the result of reporting bias or a decrease in the number
of laboratory tests.
It is important to note that this study was purely obser-
vational and therefore it is difficult to directly relate
decreased CA-MRSA infections to the educational inter-
vention. However, we did demonstrate positive knowl-
edge translation of our educational materials using pre-/
post-community surveys and a pocket chart to evaluate
the Do Bugs Need Drugs program. The pre- (n = 94) and
post-community (n = 87) surveys involved questions
regarding the appropriate usage of antimicrobials, differ-
ences between bacterial and viral infections, and overall
awareness of NARP. Improved responses to 19/20 ques-
tions were noted in the post-community education
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ments in responses for individuals who would request
antibiotics from the doctor, or seek out another doctor, if
they were not prescribed antibiotics for themselves or
their children (p = 0.004-0.03) and the importance of not
using left over antibiotics at home for new illnesses (p =
< 0.001). The Do Bugs Need Drugs pocket chart collected
data from kindergarten to grade 3 school aged children
both pre- (n = 821) and post-education (n = 685) and
demonstrated increased knowledge on the size of germs
(p = < 0.001), when and how to wash your hands (p =<
0.001 and p = 0.004, respectively), and what kind of
germs can be killed by antibiotics (p = 0.066).
Conclusions
The Germs Away curriculum is available for free down-
load and also includes a podcast series on how to teach
the program http://www.germsaway.ca. Although not
evaluated, we believe the lessons provided in the Germs
Away curriculum (e.g. proper hand washing and cough
etiquette) would be an additional valuable tool for pub-
lic health to implement in school health curriculums for
the prevention and mitigation of CA-MRSA infections,
as well as other communicable diseases. For instance,
meta-analysis of community-based hand washing cam-
paigns have shown reductions in diarrheal diseases of
approximately 30% [20] as well as some additional evi-
dence of reducing respiratory disease [21,22]. Additional
community-based NARP educational materials http://
www.narp.ca (e.g. treatment algorithms, surveillance
protocols, radio ads, posters, patient pamphlets, and
community presentation slide decks) are also freely
available http://www.narp.ca and will hopefully aid in
increasing awareness of the importance of proper anti-
microbial usage and hygiene in limiting the spread of
CA-MRSA disease in other communities. Well-con-
ducted rigorous trials are warranted in future study to
determine the direct effectiveness of this entire educa-
tional intervention strategy.
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